Medical Care
Global Nephrology Drugs Market Research Report 2025
- Apr 07, 25
- ID: 167088
- Pages: 72
- Figures: 75
- Views: 36
The global market for Nephrology Drugs was valued at US$ 735 million in the year 2024 and is projected to reach a revised size of US$ 1141 million by 2031, growing at a CAGR of 6.6% during the forecast period.
Nephrotic drugs are used to treat nephropathy. In recent years, the increase of cases of renal failure, the increase of unhealthy lifestyle adaptation, the surge in the prevalence of chronic kidney disease, the increase of the elderly population, the increase of excessive drinking and obesity have promoted the growth of nephrotic drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nephrology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nephrology Drugs.
The Nephrology Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nephrology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nephrology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Pfizer
Amgen
FibroGen
GlaxoSmithkline
AbbVie
Akebia Therapeutics
Teva Pharmaceutical Industries
Johnson & Johnson
Roche
Segment by Type
ACE Inhibitors
Calcium Channel Blocker
Beta Blockers
Diuretics
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nephrology Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nephrotic drugs are used to treat nephropathy. In recent years, the increase of cases of renal failure, the increase of unhealthy lifestyle adaptation, the surge in the prevalence of chronic kidney disease, the increase of the elderly population, the increase of excessive drinking and obesity have promoted the growth of nephrotic drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nephrology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nephrology Drugs.
The Nephrology Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nephrology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nephrology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Pfizer
Amgen
FibroGen
GlaxoSmithkline
AbbVie
Akebia Therapeutics
Teva Pharmaceutical Industries
Johnson & Johnson
Roche
Segment by Type
ACE Inhibitors
Calcium Channel Blocker
Beta Blockers
Diuretics
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nephrology Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nephrology Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ACE Inhibitors
1.2.3 Calcium Channel Blocker
1.2.4 Beta Blockers
1.2.5 Diuretics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nephrology Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nephrology Drugs Market Perspective (2020-2031)
2.2 Global Nephrology Drugs Growth Trends by Region
2.2.1 Global Nephrology Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nephrology Drugs Historic Market Size by Region (2020-2025)
2.2.3 Nephrology Drugs Forecasted Market Size by Region (2026-2031)
2.3 Nephrology Drugs Market Dynamics
2.3.1 Nephrology Drugs Industry Trends
2.3.2 Nephrology Drugs Market Drivers
2.3.3 Nephrology Drugs Market Challenges
2.3.4 Nephrology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nephrology Drugs Players by Revenue
3.1.1 Global Top Nephrology Drugs Players by Revenue (2020-2025)
3.1.2 Global Nephrology Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Nephrology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nephrology Drugs Revenue
3.4 Global Nephrology Drugs Market Concentration Ratio
3.4.1 Global Nephrology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nephrology Drugs Revenue in 2024
3.5 Global Key Players of Nephrology Drugs Head office and Area Served
3.6 Global Key Players of Nephrology Drugs, Product and Application
3.7 Global Key Players of Nephrology Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nephrology Drugs Breakdown Data by Type
4.1 Global Nephrology Drugs Historic Market Size by Type (2020-2025)
4.2 Global Nephrology Drugs Forecasted Market Size by Type (2026-2031)
5 Nephrology Drugs Breakdown Data by Application
5.1 Global Nephrology Drugs Historic Market Size by Application (2020-2025)
5.2 Global Nephrology Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nephrology Drugs Market Size (2020-2031)
6.2 North America Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nephrology Drugs Market Size by Country (2020-2025)
6.4 North America Nephrology Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nephrology Drugs Market Size (2020-2031)
7.2 Europe Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nephrology Drugs Market Size by Country (2020-2025)
7.4 Europe Nephrology Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nephrology Drugs Market Size (2020-2031)
8.2 Asia-Pacific Nephrology Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nephrology Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Nephrology Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nephrology Drugs Market Size (2020-2031)
9.2 Latin America Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nephrology Drugs Market Size by Country (2020-2025)
9.4 Latin America Nephrology Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nephrology Drugs Market Size (2020-2031)
10.2 Middle East & Africa Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nephrology Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Nephrology Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Nephrology Drugs Introduction
11.1.4 AstraZeneca Revenue in Nephrology Drugs Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Nephrology Drugs Introduction
11.2.4 Pfizer Revenue in Nephrology Drugs Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Nephrology Drugs Introduction
11.3.4 Amgen Revenue in Nephrology Drugs Business (2020-2025)
11.3.5 Amgen Recent Development
11.4 FibroGen
11.4.1 FibroGen Company Details
11.4.2 FibroGen Business Overview
11.4.3 FibroGen Nephrology Drugs Introduction
11.4.4 FibroGen Revenue in Nephrology Drugs Business (2020-2025)
11.4.5 FibroGen Recent Development
11.5 GlaxoSmithkline
11.5.1 GlaxoSmithkline Company Details
11.5.2 GlaxoSmithkline Business Overview
11.5.3 GlaxoSmithkline Nephrology Drugs Introduction
11.5.4 GlaxoSmithkline Revenue in Nephrology Drugs Business (2020-2025)
11.5.5 GlaxoSmithkline Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Nephrology Drugs Introduction
11.6.4 AbbVie Revenue in Nephrology Drugs Business (2020-2025)
11.6.5 AbbVie Recent Development
11.7 Akebia Therapeutics
11.7.1 Akebia Therapeutics Company Details
11.7.2 Akebia Therapeutics Business Overview
11.7.3 Akebia Therapeutics Nephrology Drugs Introduction
11.7.4 Akebia Therapeutics Revenue in Nephrology Drugs Business (2020-2025)
11.7.5 Akebia Therapeutics Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Details
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Nephrology Drugs Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2020-2025)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Nephrology Drugs Introduction
11.9.4 Johnson & Johnson Revenue in Nephrology Drugs Business (2020-2025)
11.9.5 Johnson & Johnson Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Nephrology Drugs Introduction
11.10.4 Roche Revenue in Nephrology Drugs Business (2020-2025)
11.10.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nephrology Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ACE Inhibitors
1.2.3 Calcium Channel Blocker
1.2.4 Beta Blockers
1.2.5 Diuretics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nephrology Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nephrology Drugs Market Perspective (2020-2031)
2.2 Global Nephrology Drugs Growth Trends by Region
2.2.1 Global Nephrology Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nephrology Drugs Historic Market Size by Region (2020-2025)
2.2.3 Nephrology Drugs Forecasted Market Size by Region (2026-2031)
2.3 Nephrology Drugs Market Dynamics
2.3.1 Nephrology Drugs Industry Trends
2.3.2 Nephrology Drugs Market Drivers
2.3.3 Nephrology Drugs Market Challenges
2.3.4 Nephrology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nephrology Drugs Players by Revenue
3.1.1 Global Top Nephrology Drugs Players by Revenue (2020-2025)
3.1.2 Global Nephrology Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Nephrology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nephrology Drugs Revenue
3.4 Global Nephrology Drugs Market Concentration Ratio
3.4.1 Global Nephrology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nephrology Drugs Revenue in 2024
3.5 Global Key Players of Nephrology Drugs Head office and Area Served
3.6 Global Key Players of Nephrology Drugs, Product and Application
3.7 Global Key Players of Nephrology Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nephrology Drugs Breakdown Data by Type
4.1 Global Nephrology Drugs Historic Market Size by Type (2020-2025)
4.2 Global Nephrology Drugs Forecasted Market Size by Type (2026-2031)
5 Nephrology Drugs Breakdown Data by Application
5.1 Global Nephrology Drugs Historic Market Size by Application (2020-2025)
5.2 Global Nephrology Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nephrology Drugs Market Size (2020-2031)
6.2 North America Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nephrology Drugs Market Size by Country (2020-2025)
6.4 North America Nephrology Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nephrology Drugs Market Size (2020-2031)
7.2 Europe Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nephrology Drugs Market Size by Country (2020-2025)
7.4 Europe Nephrology Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nephrology Drugs Market Size (2020-2031)
8.2 Asia-Pacific Nephrology Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nephrology Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Nephrology Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nephrology Drugs Market Size (2020-2031)
9.2 Latin America Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nephrology Drugs Market Size by Country (2020-2025)
9.4 Latin America Nephrology Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nephrology Drugs Market Size (2020-2031)
10.2 Middle East & Africa Nephrology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nephrology Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Nephrology Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Nephrology Drugs Introduction
11.1.4 AstraZeneca Revenue in Nephrology Drugs Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Nephrology Drugs Introduction
11.2.4 Pfizer Revenue in Nephrology Drugs Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Nephrology Drugs Introduction
11.3.4 Amgen Revenue in Nephrology Drugs Business (2020-2025)
11.3.5 Amgen Recent Development
11.4 FibroGen
11.4.1 FibroGen Company Details
11.4.2 FibroGen Business Overview
11.4.3 FibroGen Nephrology Drugs Introduction
11.4.4 FibroGen Revenue in Nephrology Drugs Business (2020-2025)
11.4.5 FibroGen Recent Development
11.5 GlaxoSmithkline
11.5.1 GlaxoSmithkline Company Details
11.5.2 GlaxoSmithkline Business Overview
11.5.3 GlaxoSmithkline Nephrology Drugs Introduction
11.5.4 GlaxoSmithkline Revenue in Nephrology Drugs Business (2020-2025)
11.5.5 GlaxoSmithkline Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Nephrology Drugs Introduction
11.6.4 AbbVie Revenue in Nephrology Drugs Business (2020-2025)
11.6.5 AbbVie Recent Development
11.7 Akebia Therapeutics
11.7.1 Akebia Therapeutics Company Details
11.7.2 Akebia Therapeutics Business Overview
11.7.3 Akebia Therapeutics Nephrology Drugs Introduction
11.7.4 Akebia Therapeutics Revenue in Nephrology Drugs Business (2020-2025)
11.7.5 Akebia Therapeutics Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Details
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Nephrology Drugs Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2020-2025)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Nephrology Drugs Introduction
11.9.4 Johnson & Johnson Revenue in Nephrology Drugs Business (2020-2025)
11.9.5 Johnson & Johnson Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Nephrology Drugs Introduction
11.10.4 Roche Revenue in Nephrology Drugs Business (2020-2025)
11.10.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nephrology Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ACE Inhibitors
Table 3. Key Players of Calcium Channel Blocker
Table 4. Key Players of Beta Blockers
Table 5. Key Players of Diuretics
Table 6. Key Players of Others
Table 7. Global Nephrology Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nephrology Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Nephrology Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Nephrology Drugs Market Share by Region (2020-2025)
Table 11. Global Nephrology Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Nephrology Drugs Market Share by Region (2026-2031)
Table 13. Nephrology Drugs Market Trends
Table 14. Nephrology Drugs Market Drivers
Table 15. Nephrology Drugs Market Challenges
Table 16. Nephrology Drugs Market Restraints
Table 17. Global Nephrology Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Nephrology Drugs Market Share by Players (2020-2025)
Table 19. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2024)
Table 20. Ranking of Global Top Nephrology Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Nephrology Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Nephrology Drugs, Headquarters and Area Served
Table 23. Global Key Players of Nephrology Drugs, Product and Application
Table 24. Global Key Players of Nephrology Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nephrology Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Nephrology Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Nephrology Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Nephrology Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Nephrology Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Nephrology Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Nephrology Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Nephrology Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Nephrology Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Nephrology Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Nephrology Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. AstraZeneca Company Details
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Nephrology Drugs Product
Table 52. AstraZeneca Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer Nephrology Drugs Product
Table 57. Pfizer Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Amgen Company Details
Table 60. Amgen Business Overview
Table 61. Amgen Nephrology Drugs Product
Table 62. Amgen Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 63. Amgen Recent Development
Table 64. FibroGen Company Details
Table 65. FibroGen Business Overview
Table 66. FibroGen Nephrology Drugs Product
Table 67. FibroGen Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 68. FibroGen Recent Development
Table 69. GlaxoSmithkline Company Details
Table 70. GlaxoSmithkline Business Overview
Table 71. GlaxoSmithkline Nephrology Drugs Product
Table 72. GlaxoSmithkline Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 73. GlaxoSmithkline Recent Development
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Nephrology Drugs Product
Table 77. AbbVie Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 78. AbbVie Recent Development
Table 79. Akebia Therapeutics Company Details
Table 80. Akebia Therapeutics Business Overview
Table 81. Akebia Therapeutics Nephrology Drugs Product
Table 82. Akebia Therapeutics Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 83. Akebia Therapeutics Recent Development
Table 84. Teva Pharmaceutical Industries Company Details
Table 85. Teva Pharmaceutical Industries Business Overview
Table 86. Teva Pharmaceutical Industries Nephrology Drugs Product
Table 87. Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 88. Teva Pharmaceutical Industries Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Nephrology Drugs Product
Table 92. Johnson & Johnson Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Nephrology Drugs Product
Table 97. Roche Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 98. Roche Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Nephrology Drugs Picture
Figure 2. Global Nephrology Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nephrology Drugs Market Share by Type: 2024 VS 2031
Figure 4. ACE Inhibitors Features
Figure 5. Calcium Channel Blocker Features
Figure 6. Beta Blockers Features
Figure 7. Diuretics Features
Figure 8. Others Features
Figure 9. Global Nephrology Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Nephrology Drugs Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacy Case Studies
Figure 12. Retail Pharmacy Case Studies
Figure 13. Online Pharmacy Case Studies
Figure 14. Nephrology Drugs Report Years Considered
Figure 15. Global Nephrology Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nephrology Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nephrology Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Nephrology Drugs Market Share by Players in 2024
Figure 19. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nephrology Drugs Revenue in 2024
Figure 21. North America Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nephrology Drugs Market Share by Country (2020-2031)
Figure 23. United States Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nephrology Drugs Market Share by Country (2020-2031)
Figure 27. Germany Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nephrology Drugs Market Share by Region (2020-2031)
Figure 35. China Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nephrology Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nephrology Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AstraZeneca Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 52. Amgen Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 53. FibroGen Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 54. GlaxoSmithkline Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 55. AbbVie Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 56. Akebia Therapeutics Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 57. Teva Pharmaceutical Industries Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 58. Johnson & Johnson Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 59. Roche Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Nephrology Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ACE Inhibitors
Table 3. Key Players of Calcium Channel Blocker
Table 4. Key Players of Beta Blockers
Table 5. Key Players of Diuretics
Table 6. Key Players of Others
Table 7. Global Nephrology Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nephrology Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Nephrology Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Nephrology Drugs Market Share by Region (2020-2025)
Table 11. Global Nephrology Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Nephrology Drugs Market Share by Region (2026-2031)
Table 13. Nephrology Drugs Market Trends
Table 14. Nephrology Drugs Market Drivers
Table 15. Nephrology Drugs Market Challenges
Table 16. Nephrology Drugs Market Restraints
Table 17. Global Nephrology Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Nephrology Drugs Market Share by Players (2020-2025)
Table 19. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2024)
Table 20. Ranking of Global Top Nephrology Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Nephrology Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Nephrology Drugs, Headquarters and Area Served
Table 23. Global Key Players of Nephrology Drugs, Product and Application
Table 24. Global Key Players of Nephrology Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nephrology Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Nephrology Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Nephrology Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Nephrology Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Nephrology Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Nephrology Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Nephrology Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Nephrology Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Nephrology Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Nephrology Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Nephrology Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Nephrology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Nephrology Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Nephrology Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. AstraZeneca Company Details
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Nephrology Drugs Product
Table 52. AstraZeneca Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer Nephrology Drugs Product
Table 57. Pfizer Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Amgen Company Details
Table 60. Amgen Business Overview
Table 61. Amgen Nephrology Drugs Product
Table 62. Amgen Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 63. Amgen Recent Development
Table 64. FibroGen Company Details
Table 65. FibroGen Business Overview
Table 66. FibroGen Nephrology Drugs Product
Table 67. FibroGen Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 68. FibroGen Recent Development
Table 69. GlaxoSmithkline Company Details
Table 70. GlaxoSmithkline Business Overview
Table 71. GlaxoSmithkline Nephrology Drugs Product
Table 72. GlaxoSmithkline Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 73. GlaxoSmithkline Recent Development
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Nephrology Drugs Product
Table 77. AbbVie Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 78. AbbVie Recent Development
Table 79. Akebia Therapeutics Company Details
Table 80. Akebia Therapeutics Business Overview
Table 81. Akebia Therapeutics Nephrology Drugs Product
Table 82. Akebia Therapeutics Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 83. Akebia Therapeutics Recent Development
Table 84. Teva Pharmaceutical Industries Company Details
Table 85. Teva Pharmaceutical Industries Business Overview
Table 86. Teva Pharmaceutical Industries Nephrology Drugs Product
Table 87. Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 88. Teva Pharmaceutical Industries Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Nephrology Drugs Product
Table 92. Johnson & Johnson Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Nephrology Drugs Product
Table 97. Roche Revenue in Nephrology Drugs Business (2020-2025) & (US$ Million)
Table 98. Roche Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Nephrology Drugs Picture
Figure 2. Global Nephrology Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nephrology Drugs Market Share by Type: 2024 VS 2031
Figure 4. ACE Inhibitors Features
Figure 5. Calcium Channel Blocker Features
Figure 6. Beta Blockers Features
Figure 7. Diuretics Features
Figure 8. Others Features
Figure 9. Global Nephrology Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Nephrology Drugs Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacy Case Studies
Figure 12. Retail Pharmacy Case Studies
Figure 13. Online Pharmacy Case Studies
Figure 14. Nephrology Drugs Report Years Considered
Figure 15. Global Nephrology Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nephrology Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nephrology Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Nephrology Drugs Market Share by Players in 2024
Figure 19. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nephrology Drugs Revenue in 2024
Figure 21. North America Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nephrology Drugs Market Share by Country (2020-2031)
Figure 23. United States Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nephrology Drugs Market Share by Country (2020-2031)
Figure 27. Germany Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nephrology Drugs Market Share by Region (2020-2031)
Figure 35. China Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nephrology Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nephrology Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nephrology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AstraZeneca Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 52. Amgen Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 53. FibroGen Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 54. GlaxoSmithkline Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 55. AbbVie Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 56. Akebia Therapeutics Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 57. Teva Pharmaceutical Industries Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 58. Johnson & Johnson Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 59. Roche Revenue Growth Rate in Nephrology Drugs Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232